Charles Harris is a seasoned professional in the field of diabetes, obesity, and complications therapeutic areas, currently serving as the Associate Vice President at Eli Lilly and Company since 2024. They previously held the position of Executive Director at the same company from 2022 to 2024 and worked as an Associate Medical Director at Regeneron Pharmaceuticals from 2019 to 2022. Harris has a rich background in clinical medicine, having served as a Staff Physician at the Veterans Affairs Medical Center from 2013 to 2019 and as a Staff Scientist at the J David Gladstone Institute from 2008 to 2012. They completed their MD/PhD in Medicine and Neuroscience at Washington University School of Medicine, followed by advanced training as an Endocrine Fellow at UCSF and a residency at Washington University School of Medicine.
This person is not in any teams
This person is not in any offices